Bank of Montreal’s IGM Biosciences IGMS Stock Holding History

Bank of Montreal’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-217	Closed	-$17K	–	4245
2021 Q1	$17K	Sell	217 -875	-80%	-$79.6K	﹤0.01%	4121
2020 Q4	$93K	Buy	1,092 +765	+234%	+$53.8K	﹤0.01%	3623
2020 Q3	$24K	Sell	327 -240	-42%	-$14.2K	﹤0.01%	3756
2020 Q2	$41K	Buy	+567	New	+$34.4K	﹤0.01%	3518
2020 Q1	–	Sell	-625	Closed	-$24K	–	4359
2019 Q4	$24K	Buy	+625	New	+$15.7K	﹤0.01%	4215

Other funds holding IGMS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Montreal's IGMS Position: Q2 2021 in Review

Bank of Montreal sold out of IGM Biosciences (IGMS) in Q2 2021, closing a stake of 217 shares — an estimated $17K sold.

Bank of Montreal first reported a position in IGMS in Q4 2019 and held it in 5 quarters. The position peaked at $93K in Q4 2020. 104 funds tracked by Wall St. Rank hold IGMS as of Q2 2021.

Bank of Montreal reported no remaining IGM Biosciences position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 217 IGM Biosciences shares in Q2 2021, an estimated $17K.
Bank of Montreal first reported a position in IGM Biosciences in Q4 2019 and held it in 5 quarters.
Bank of Montreal's IGM Biosciences position peaked at $93K in Q4 2020.
104 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.